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The purpose of this editorial is to renew the call for assess-
ing and documenting clinical significance/social validity in
our intervention research. Clinical significance/social valid-
ity needs to be documented at three levels: (1) the goals of
our intervention studies are relevant to interested parties,
such as children, parents, referral sources, and third party
payers; (2) the intervention procedures are acceptable to
interested parties and are therefore more likely to be
adopted if effective; and (3) the effects of our interventions
are satisfactory to consumers and meet some standard
of achieving clinically significant effects. This editorial
describes methods for assessing clinical significance/
social validity at all three levels.
A statistically significant treatment effect gives us con-
fidence that an effect is not due to chance. However, a
statistically significant effect does not inform us about
the size, importance, or clinical significance of the effect.
Even ‘‘effect sizes’’ (using Cohen’s convention of r¼ .10 as
small, r¼ .30 as medium, and r¼ .50 as large; Cohen,
1988), do not determine if the threshold for clinical sig-
nificance has been reached. For example, the effect size for
low-dose aspirin used to prevent first heart attacks was
r¼ .02, which is less than a ‘‘small’’ effect size according
to Cohen. However in that study, the sample size was large
(22,071) and the risk reduction was 44% (p.00001).
Consequently, the trial was prematurely stopped due to
the obvious benefits of low-dose aspirin (Steering
Committee of the Physicians’ Health Study Research
Group, 1988).
There have been previous admonitions published
in this journal about the need to document clinical sig-
nificance/social validity in intervention research in pedi-
atric psychology (Drotar, 1997, 2008, 2009; Drotar &
Lemanek, 2001). The purpose of this editorial is to
renew that call for assessing and documenting clinical
significance/social validity in our intervention research.
My objectives are to (1) define clinical significance and
social validity, and (2) describe ways to assess clinical
significance and social validity using examples from the
literature.
Definitions of Clinical Significance and
Social Validity
‘‘The clinical significance of a treatment refers to its ability
to meet standards of efficacy set by consumers, clinicians,
and researchers’’ (Jacobson & Truax, 1991, p. 12). The
term social validity comes out of the applied behavior
analysis tradition and is a broader and more inclusive
term than clinical significance. Social validity is assessed
at three levels (Kazdin, 1977; Wolf, 1978):
 Goals: Are the specific goals of treatment what society
wants? Do they focus on goals relevant to interested
parties such as children, parents, referral sources, and
third party payers?
 Procedures: Are the treatment procedures acceptable to
consumers in terms of costs, ethics, and practicality?
 Effects: Are effects of an intervention satisfactory to
consumers?
Assessing and Documenting Clinical
Significance/Social Validity
Treatment Goals
One method for ensuring that treatment goals are relevant
is to ask consumers to choose their own goals and then use
goal attainment scaling (GAS) to rate changes in these goals
after treatment. Goal attainment scaling is a statistically
validated and reliable measure of valued goals chosen by
consumers to represent their definition of improvement in
their health (see Fisher, 2008 for an example with chronic
pain patients).
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Prior to developing interventions, we can also obtain
information from consumers that will help us focus our
interventions on relevant goals. For example, two surveys
of parents whose children have juvenile arthritis found that
adherence to therapeutic exercise was more problematic
for the children than taking medications, suggesting
that we focus adherence interventions on this regimen
component (Hayford & Ross, 1988; Rapoff, Lindsley, &
Christophersen, 1985). In addition, there is a growing
body of literature assessing barriers to adherence among
children with chronic illnesses and their parents (Modi &
Quittner, 2006; Modi et al., 2009; Reikert & Drotar,
2002). Interventions can be targeted to specific barriers
identified by children or parents (Rapoff, in press).
Treatment Procedures
We may have effective interventions but if children and
parents do not find them acceptable, they will not use
them. The social validity of treatment procedures can be
assessed by asking parents and children to provide Likert-
type ratings of acceptability and asking if they would
recommend the intervention to others. This has been
done by parents for a treatment program for bedtime pro-
blems (Burke, Kuhn, & Peterson, 2004), by adolescents
with diabetes and their parents for a conflict resolution
program (Wysocki et al., 1997), and by pediatricians, par-
ents, and pediatric psychologists for a thumb sucking
intervention (Friman & Leibowitz, 1990). In terms of spe-
cific techniques, such as positive reinforcement and time-
out, those designed to increase positive behaviors are rated
as more acceptable than those designed to reduce inappro-
priate behaviors (Calvert & Johnston, 1990). Treatments
are also rated as more acceptable when they achieve rapid
success, when they have few side-effects, and when they
are not as complex and time intensive (Calvert & Johnston,
1990).
Kazdin (1980) was the first to develop and validate a
generic instrument (the Treatment Evaluation Inventory;
TEI) for assessing treatment acceptability. The TEI is a
15-item questionnaire with items rated on a 7-point
Likert scale. The TEI or modifications of it have been
used in many studies to rate treatment acceptability
(Kelley, Heffer, Gresham, & Elliott, 1989; Reimers,
Wacker, & Koeppl, 1987; Spirrison, Noland, & Savoie,
1992; Witt & Martens, 1983).
Treatment Outcomes
The most ubiquitous assessment of clinical significance/
social validity is at the level of treatment outcomes. The
most straightforward criterion for determining significance
is if treatment increased survival rates (e.g., greater
adherence lead to lower mortality rates in the treatment
of HIV/AIDS). Also if a treatment eliminates a problem, no
one would argue that a clinical significant effect has been
obtained. For example, Frank, Spirito, Stark, and Owens-
Stively (1997) showed that sleep walking could be elimi-
nated in three children using a scheduled awakening pro-
cedure. Generally, survival or cures are not reasonable
goals for most of our interventions in pediatric psychology.
Subjective Judgments or Observations
We can ask relevant consumers to make retrospective judg-
ments about whether they improved, stayed the same, or
became worse following treatment (Norman, Sloan, &
Wyrwich, 2003). These can be as fine grained as research-
ers would like them to be, for example, using a 7-point
Likert scale to rate the degree to which the person
improved. We can also ask judges to rate observations
for evidence of changes following intervention. For
example, Finney, Rapoff, Hall, and Christophersen
(1983) had teachers and graduate students rate randomly
chosen videotapes at baseline and post-treatment for the
presence of ‘‘distracting’’ behaviors of two adolescents
treated for tic disorders. The ratings were much lower at
post-treatment which was in agreement with objective
coding of tic behaviors by trained observers.
Reliable Improvements
Before comparing treated clients to normative groups,
some have argued that we need to first determine if the
magnitude of change for individual patients treated is stat-
istically reliable. The most popular index for doing this in
the literature is the Reliable Change Index (RCI) proposed
by Jacobson & Truax (1991). The formula for calculating




where xpost is the person’s post-test score, xpre is the per-
son’s pre-test score, and Sdiff is the standard error of the
difference between two scores.
The change is considered reliable or unlikely due to
measurement error if the RCI is greater than 1.96 (Ogles,
Lunnen, & Bonesteel, 2001).
Others have argued for using the Standard Error of
Measurement (SEM) to determine if a reliable and mean-
ingful change has occurred (Eisen, Ranganathan, Seal, &
Spiro, 2007; Guyatt, 2000). The SEM is the standard
deviation (SD) of an individual score which is calculated
by multiplying the SD for a sample by the square root
of one minus its reliability coefficient and an SEM of 1
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or higher is said to be indicative of a clinically important
change (Eisen et al., 2007).
Normative Comparisons
Normative data have been collected on health-related qual-
ity of life measures for healthy and ill children (e.g., Varni,
Seid, Knight, Uzark, & Szer, 2002; Varni, Seid, & Kurtin,
2001), for observational measures of social interaction for
preschool children (Greenwood, Walker, Todd, & Hops,
1981), and observational measures of mealtime behaviors
of families of children with cystic fibrosis and families of
children with no chronic illness (Spieth et al., 2001). Also,
widely used instruments for assessing emotional and be-
havioral functioning, such as the Child Behavior Checklist
(CBCL), have predetermined cutoff scores based on exten-
sive normative data to indicate clinically significant levels
of problem behaviors. For example, March, Spence, and
Donovan (2009) used a T score of <65 on the internaliz-
ing subscale of the CBCL to evaluate whether clinically
significant change occurred following an internet-based
cognitive-behavioral treatment for child anxiety disorders.
They did an analysis with 41 of their 73 participants who
had pretreatment CBCL internalizing T scores greater than
65 and found that 58% in the treatment group were less
than 65 after treatment compared with 46% in the control
group. Thus, following treatment we would want our
patients to resemble their healthy or normal peers or
maybe no longer meet criteria for a psychiatric disorder
that prompted treatment (Kazdin, 2008).
The problem with this approach is that normative data
and standardized cutoff scores may not exist or may be
undesirable. Take the example of adherence to regimens
for chronic illness. I calculated the mean level of adher-
ence, SD, and range (R) for studies reviewed in the first
chapter of my book on three different diseases (Rapoff, in
press, Table 1.2). Across 18 studies examining adherence
to medications for asthma the mean rate was 50%
(SD¼ 22%, R¼ 10–85%); across 17 studies examining
adherence to a gluten-free diet for celiac disease the
mean rate was 69% (SD¼ 19%, R¼ 30–95%); and
across 7 studies examining adherence to antiretroviral
drugs in the treatment of HIV/AIDS the mean rate was
75% (SD¼ 14%, R¼ 54–93%). What are we to make of
these data? Is this an adequate level of adherence consider-
ing that the average rate of adherence across all regimens
for pediatric chronic diseases is estimated to be between 50
and 55% (Rapoff, in press)? The answer is that for most
diseases and regimens we do not know the minimum level
of adherence necessary to achieve an acceptable thera-
peutic response (Gordis, 1979; Haskard, DiMatteo, &
Williams, 2009). The standard in the literature has been
an adherence rate of 80% or better but this was based on
early data on adult hypertensive patients where that level of
adherence to antihypertensive medications resulted in
adequate blood pressure control. For diseases like HIV/
AIDS, an adherence level of 90 or 95% may be necessary
to achieve adequate suppression of the virus (Rapoff, in
press).
Standards Determined by Expert Consensus
In the pain literature, extensive studies and reviews have
been done to determine clinically significant changes in
measures of pain intensity. The consensus from many stu-
dies by different investigators is that a 2-point change on a
0–10 pain rating scale is a meaningful change in pain in-
tensity (Farrar, Portenoy, Berlin, Kinman, & Strom, 2000;
Farrar, Young, LaMoreaux, Werth, & Poole, 2001). Others
have suggested a 50% reduction in pain scores from base-
line to post-treatment for individual patients (Hicks, von
Baeyer, & McGrath, 2006). Other intervention studies
used expert opinion to establish standards for meaningful
clinical change, such as pedodontists recommending
plaque levels less than or equal to 20% for children
(Dahlquist et al., 1985) and an NIH consensus panel rec-
ommending optimal calcium intake levels of 1500 Ca per
day for children (Stark et al., 2005).
Use Single Subject Designs
Although randomized, between-groups, controlled clinical
trials are considered the ‘‘gold standard’’ for experimental-
ly evaluating the efficacy of treatments, there is a long
tradition in medicine and psychology of investigating the
effects of interventions at the individual level using single-
subject designs (Barlow, Nock, & Hersen, 2009). Single-
subject designs offer a number of advantages over trad-
itional group designs: (1) they provide flexibility in the
choice of independent variables and allowance for changes
in these over the course of a study (if something is not
working, an intervention can be modified and introduced
as a new condition); (2) they accommodate small sample
sizes (appropriate for studying rare conditions or smaller
sample sizes available at any one site); (3) they are better at
exposing individual variability in outcome measures and if
an individual patient has made a clinically meaningful
change; (4) they produce results that are more easily
understood by clinicians (who work at the level of individ-
ual patients); and (5) they are recognized as legitimate
designs that can help to establish empirically validated
treatments and evidence-based practices (Barlow et al.,
2009; Rapoff & Stark, 2008). The most common designs
are the reversal and multiple baseline designs that can be
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used with one patient or more (see Barlow et al., 2009 for
the authoritative book on single-subject designs).
For example, we did a study with a 14-year-old male
with juvenile rheumatoid arthritis who was non-adherent
to a non-steriodal anti-inflammatory medication (Rapoff,
Purviance, & Lindsley, 1988). Table I shows the results
of the study by phase using a reversal design in terms of
the effect on adherence and a clinical outcome (active joint
count). It can clearly be seen that the token system inter-
vention improved adherence. In addition, improvements in
adherence were also associated with a change in a mean-
ingful clinical parameter. At the level of the individual,
single-subject designs allow us to determine if a noticeable
change has occurred as the result of interventions.
Assess Changes in Clinically Relevant Collateral
Measures
As illustrated in Table I, we should not only assess primary
outcomes (such as measures of adherence) but other
clinically relevant measures to see if they change in the
expected direction and in tandem with changes in the
target measures. For example, in adherence intervention
studies, we should assess clinical outcome measures,
such as pulmonary function for children with asthma,
and quality of life measures (Rapoff, in press).
Conclusions
In designing and then submitting intervention studies to
the Journal of Pediatric Psychology, I would strongly recom-
mend that investigators include a measure of clinical sig-
nificance/social validity at least at the level of treatment
outcomes. Documenting the clinical significance of inter-
vention studies is important to the growth of our field
and is a priority for the Journal of Pediatric Psychology.
Hopefully, suggestions in this editorial will be helpful in
this endeavor. We need to start somewhere and as Alan
Kazdin (2008) has said: ‘‘Let us not begin with what
cannot be done’’ (p. 155).
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